NATALIE LUKASZEWSKI: Open Payments
NPI 1518275411 · CHEVY CHASE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,590 in 67 payments from 17 companies in 2025. Trend: 2023 $1,940 · 2024 $1,683 · 2025 $1,590
Food & beverage: $1,490Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $327 |
| Galderma Laboratories, L.P. | 13 | $263 |
| Janssen Biotech, Inc. | 10 | $212 |
| PFIZER INC. | 3 | $152 |
| Medimetriks Pharmaceuticals, Inc. | 5 | $96 |
| GENZYME CORPORATION | 2 | $79 |
| Organon LLC | 3 | $74 |
| UCB, Inc. | 3 | $70 |
| Botanix SB Inc | 3 | $66 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
Products named: NEMLUVIO, TREMFYA, BOTOX, CIBINQO, SKYRIZI, DUPIXENT, Bimzelx, SOFDRA.
Industry payments across MD — which companies pay providers there.
